Case report: Exploring efficacy of tofacitinib in modulating interferon response in five case of anti-MDA5+ dermatomyositis with interstitial lung disease
A case report highlights the challenges faced in managing a 66-year-old Chinese woman diagnosed with anti-MDA5 antibody-positive dermatomyositis (MDA5-DM) complicated by rapidly progressive interstitial lung disease (RP-ILD). Despite aggressive therapeutic interventions, her condition rapidly deteri...
Saved in:
Main Authors: | Jie Zhao, Yan Bao, Ying Gao, Keliang Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1515602/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophil-to-lymphocyte ratio and short-term mortality in patients having anti-MDA5-positive dermatomyositis with interstitial lung disease: a retrospective study
by: Hongxia Xin, et al.
Published: (2025-01-01) -
Improvement of Fatigue in Patients with Ankylosing Spondylitis Receiving Tofacitinib: Analyses of a Phase 3 Randomized Controlled Trial
by: Laure Gossec, et al.
Published: (2024-12-01) -
The effect of interferon alpha administration on cytokine levels in sheep
by: Devran Coşkun, et al.
Published: (2020-12-01) -
HIV and diabetes impair M. tuberculosis-specific interferon-gamma responses on QuantiFERON-TB Gold Plus testing
by: J.S. Zifodya, et al.
Published: (2024-05-01) -
Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
by: Xiaoping Li, et al.
Published: (2025-01-01)